Pharmacy Diversion Awareness Conference
April 5 & 6, 2014; Hilton St. Louis at the Ballpark; St. Louis, Missouri
The Drug Enforcement Administration (DEA) held a Pharmacy Diversion Awareness Conference (PDAC) on April 5th and 6th, 2014 in St. Louis, Missouri. This was a one-day conference, repeated on the second day, for the convenience of the pharmacy community. The conference was developed and designed to address the growing problem of diversion of pharmaceutical controlled substances throughout the United States. In addition to pharmacy robberies and thefts, pharmaceutical controlled substances are often diverted by way of forged prescriptions, doctor shoppers, or illegitimate prescriptions from rogue practitioners. The objective of this conference was to educate pharmacists, pharmacy technicians, and pharmacy loss prevention personnel on ways to address and respond to potential diversion activity.
Over 220 pharmacists, pharmacy technicians, loss prevention personnel, and pharmaceutical students attended. The conference attendees received seven hours of instruction on a variety of topics. The presentations included: Drug Trends, Drugs, Drugs and More Drugs, Bureau of Narcotics and Dangerous Drugs (BNDD) Update, CMEA Requirements for Retail Distributors, and Diversion Issues.
Presentations from the St. Louis PDAC, as well as a link to the Pharmacy Robbery & Burglary brochure are below.
Drug Trends – Robert L. Hill, Executive Assistant, DEA Office of Diversion Control
Drugs, Drugs, and More Drugs – Thomas Prevoznik, Staff Coordinator, Liaison and Policy Section/DEA Office of Diversion Control
Missouri Bureau of Narcotics and Dangerous Drugs (BNDD) Update – Michael R. Boeger, Administrator, Missouri BNDD
Medicare Pharmaceutical Diversion – Les W. Hollie, Assistant Inspector General, OIG/Health and Human Services
Pharmacy Theft and Robbery Prevention – Frank A. Magel, Detective, Missouri State Highway Patrol/DEA St. Louis Tactical Diversion Squad
Drug Theft Prevention – Cathy Gallagher, Section Chief, Liaison and Policy Section/DEA Office of Diversion Control